Expression of CD69, a marker for tissue-resident lymphocytes, was more frequently expressed toward the tumor center on CD16− NK cells and CD8+ T cells and in a similar but non-significant trend on CD4+ T cells, while nearly all ILCs expressed CD69 at all locations studied (Figure 1d, Figure S1E, F). The gene discussed is CD69; the disease is neoplasm.